Main container

Solitary fibrous tumor: phase II study on TRabectedin versus Adriamycin plus DAcarbazine in advanced patients (STRADA)

Title
Solitary fibrous tumor: phase II study on TRabectedin versus Adriamycin plus DAcarbazine in advanced patients (STRADA)
Code
ISG-STRADA
Type
Sperimentale
Start Year
2019
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Description

Studio clinico no profit di Fase 2 con Trabectidina versus Adriamicina in combinazione con Decarbazina in pazienti adulti con Tumore Fibroso Solitario avanzato o metastatico. Lo studio è promosso da Italian Sarcoma Group-I.S.G.

Tutti i medici oncologi dell'Osteoncologia sono co-investigator e quindi arruolano pazienti per questo studio.

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more